BCHE and Alzheimer disease: In AD, cholinesterase inhibitors (e.g., donepezil and rivastigmine) and NMDA (N-methyl-D-aspartate) receptor antagonists (e.g., memantine) are used to alleviate cognitive symptoms by enhancing cholinergic function and modulating glutamatergic transmission.